265 related articles for article (PubMed ID: 19520971)
1. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.
Koitabashi N; Bedja D; Zaiman AL; Pinto YM; Zhang M; Gabrielson KL; Takimoto E; Kass DA
Circ Res; 2009 Jul; 105(1):12-5. PubMed ID: 19520971
[TBL] [Abstract][Full Text] [Related]
2. 4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice.
Heinen A; Gödecke S; Flögel U; Miklos D; Bottermann K; Spychala A; Gödecke A
Basic Res Cardiol; 2021 Feb; 116(1):8. PubMed ID: 33544211
[TBL] [Abstract][Full Text] [Related]
3.
Wang X; Lauth A; Wan TC; Lough JW; Auchampach JA
Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33106234
[TBL] [Abstract][Full Text] [Related]
4. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.
Sohal DS; Nghiem M; Crackower MA; Witt SA; Kimball TR; Tymitz KM; Penninger JM; Molkentin JD
Circ Res; 2001 Jul; 89(1):20-5. PubMed ID: 11440973
[TBL] [Abstract][Full Text] [Related]
5. Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice.
Hougen K; Aronsen JM; Stokke MK; Enger U; Nygard S; Andersson KB; Christensen G; Sejersted OM; Sjaastad I
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1671-8. PubMed ID: 20802136
[TBL] [Abstract][Full Text] [Related]
6. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice.
Hall ME; Smith G; Hall JE; Stec DE
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H253-60. PubMed ID: 21536850
[TBL] [Abstract][Full Text] [Related]
7. Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death.
Bersell K; Choudhury S; Mollova M; Polizzotti BD; Ganapathy B; Walsh S; Wadugu B; Arab S; Kühn B
Dis Model Mech; 2013 Nov; 6(6):1459-69. PubMed ID: 23929941
[TBL] [Abstract][Full Text] [Related]
8. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
Xiong D; Yajima T; Lim BK; Stenbit A; Dublin A; Dalton ND; Summers-Torres D; Molkentin JD; Duplain H; Wessely R; Chen J; Knowlton KU
Circulation; 2007 Jan; 115(1):94-102. PubMed ID: 17190866
[TBL] [Abstract][Full Text] [Related]
9. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.
Buerger A; Rozhitskaya O; Sherwood MC; Dorfman AL; Bisping E; Abel ED; Pu WT; Izumo S; Jay PY
J Card Fail; 2006 Jun; 12(5):392-8. PubMed ID: 16762803
[TBL] [Abstract][Full Text] [Related]
10. Generation of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studies.
Yan J; Sultana N; Zhang L; Park DS; Shekhar A; Hu J; Bu L; Cai CL
Genesis; 2015 Jun; 53(6):377-86. PubMed ID: 26010701
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Cre-mediated genetic deletion of
Garbern J; Kristl AC; Bassaneze V; Vujic A; Schoemaker H; Sereda R; Peng L; Ricci-Blair EM; Goldstein JM; Walker RG; Bhasin S; Wagers AJ; Lee RT
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H201-H212. PubMed ID: 31125255
[TBL] [Abstract][Full Text] [Related]
13. Generation of NSE-MerCreMer transgenic mice with tamoxifen inducible Cre activity in neurons.
Kam MK; Lee KY; Tam PK; Lui VC
PLoS One; 2012; 7(5):e35799. PubMed ID: 22586451
[TBL] [Abstract][Full Text] [Related]
14. A Murine Myh6MerCreMer Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction.
Yan J; Zhang L; Sultana N; Park DS; Shekhar A; Bu L; Hu J; Razzaque S; Cai CL
PLoS One; 2015; 10(7):e0133472. PubMed ID: 26204265
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal mapping of the αMHC-MerCreMer transgene in mice reveals a large genomic deletion.
Harkins S; Whitton JL
Transgenic Res; 2016 Oct; 25(5):639-48. PubMed ID: 27165291
[TBL] [Abstract][Full Text] [Related]
16. Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination.
Petrich BG; Molkentin JD; Wang Y
FASEB J; 2003 Apr; 17(6):749-51. PubMed ID: 12594183
[TBL] [Abstract][Full Text] [Related]
17. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
[TBL] [Abstract][Full Text] [Related]
18. Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.
Noh HL; Okajima K; Molkentin JD; Homma S; Goldberg IJ
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E755-60. PubMed ID: 16684851
[TBL] [Abstract][Full Text] [Related]
19. PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heart.
McLean BA; Zhabyeyev P; Patel VB; Basu R; Parajuli N; DesAulniers J; Murray AG; Kassiri Z; Vanhaesebroeck B; Oudit GY
Cardiovasc Res; 2015 Mar; 105(3):292-303. PubMed ID: 25618408
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.
Jia Y; Chang HC; Schipma MJ; Liu J; Shete V; Liu N; Sato T; Thorp EB; Barger PM; Zhu YJ; Viswakarma N; Kanwar YS; Ardehali H; Thimmapaya B; Reddy JK
PLoS One; 2016; 11(8):e0160755. PubMed ID: 27548259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
